Compare ATYR & MMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATYR | MMTX |
|---|---|---|
| Founded | 2005 | 2025 |
| Country | United States | Taiwan |
| Employees | 58 | 2 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 88.1M |
| IPO Year | N/A | N/A |
| Metric | ATYR | MMTX |
|---|---|---|
| Price | $0.83 | $10.03 |
| Analyst Decision | Hold | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $3.67 | N/A |
| AVG Volume (30 Days) | ★ 948.2K | 1.1K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $139.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.64 | $9.89 |
| 52 Week High | $7.29 | $10.03 |
| Indicator | ATYR | MMTX |
|---|---|---|
| Relative Strength Index (RSI) | 50.11 | 70.17 |
| Support Level | $0.68 | $9.90 |
| Resistance Level | $0.86 | N/A |
| Average True Range (ATR) | 0.05 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 68.00 | 100.00 |
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
Miluna Acquisition Corp is a blank check company.